Voiding Efficiency, a Predictor of Clean Intermittent Catheterization (CIC)
| Status: | Active, not recruiting |
|---|---|
| Conditions: | Overactive Bladder |
| Therapuetic Areas: | Gastroenterology |
| Healthy: | No |
| Age Range: | 18 - Any |
| Updated: | 2/27/2019 |
| Start Date: | May 12, 2017 |
| End Date: | June 30, 2019 |
Voiding Efficiency, a Predictor of CIC
This study is a retrospective chart review of patients treated with onabotulinumtoxinA
(BOTOX®) for idiopathic overactive bladder (OAB) and will determine voiding efficiency (VE)
cutoff ratios that predict post-procedure urinary retention requiring catheterization.
(BOTOX®) for idiopathic overactive bladder (OAB) and will determine voiding efficiency (VE)
cutoff ratios that predict post-procedure urinary retention requiring catheterization.
Inclusion Criteria:
- Patient with documented idiopathic OAB diagnosis
- Patient was treated with 100-200U of BOTOX® for OAB
- Urodynamics assessment within prior to first BOTOX® injection.
Exclusion Criteria:
- Patient had received botulinum toxin formulations other than BOTOX® in the bladder
- Patient had symptoms of OAB associated with a neurological condition (eg, spinal cord
injury, multiple sclerosis, cerebrovascular accident, Alzheimer's disease, Parkinson's
disease, etc).
We found this trial at
3
sites
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials